Mr Mrs Miss Ms Dr Other

Mr
Daniel
Wolstenholme

Patent Director

Birmingham Office

Chemistry

Telephone. +44(0) 121 265 7930
Email. dwolstenholme@hgf.com
UPC Representative
Our team of specialist European patent litigators, oppositions specialists and patent attorneys bring together an extensive depth of legal and technical knowledge and are qualified to represent you in the UPC.

Experience

Daniel is an experienced European and Chartered (UK) Patent Attorney with over a decade of experience in Intellectual Property.

Daniel has an academic background in Chemistry, but has spent his career across both chemical and mechanical engineering fields. He has worked with a broad range of technology, including recycling and waste-to-energy systems, foundry products, food science, construction products, medical devices, and oil-and-gas systems.

With a heavy emphasis on direct client work and including a client secondment for a number of years, Daniel has extensive experience advising businesses all the way from initial inception through to product launch, including critical processes such as IP searching, freedom-to-operate, and infringement analysis.

Qualifications

Patent Attorney

Chartered (UK)
Europe


BSC

Chemistry

POSTGRADUATE DIPLOMA OR CERTIFICATE

Intellectual Property

Related News

Event - 23rd - 25th March 2026

HGF are Gold Sponsors of IPBC Europe 2026

HGF are proud sponsors of IPBC Europe 2026, taking place from 23-25 March 2026 at the Pullman Paris Montparnasse. Bringing together patent pioneers, in-house leaders and private practice specialists, IPBC …

Event details
Event - 8th - 11th February 2026

AUTM Meeting 2026

We are attending the AUTM Annual Meeting from 8–11 February, a flagship event bringing together technology transfer professionals from across the globe. AUTM connects innovators, universities, and industry leaders to …

Event details

The Antibody Series #4 | pH points in antibody claims: when “same pH ” becomes an addition of matter

The Boards of Appeal of the EPO (BoA) are the appeal body that reviews EPO decisions; in this case, they reviewed a revocation in opposition of a patent relating to …

Read article

The Antibody Series #2 | Definition via binding strength in antibody claims: when “binds strongly... but only minimally...” becomes a trap of lack of clarity

Defining an antibody by its binding strength is common practice in patent claims, but it can quickly become a pitfall under Article 84 EPC on clarity. In this second installment …

Read article
Event - 3rd February 2026

HGF Brand & Design Conference 2026

Join us on 3rd February 2026 for HGF’s Brand & Design Conference, the must attend event for in-house legal teams, brand leaders, creatives, and innovators shaping the future of IP. …

Event details
Event - 14th January 2026

Seminar on The aftermath of G1/24 - has anything changed?

HGF is hosting a The aftermath of G1/24 – has anything changed? Which will be followed by networking, apero, and snacks. The Seminar will be held on Wednesday, 14th January …

Event details

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.